Myocardial Ischemia, Physical Exercise
Conditions
Keywords
Cardiac Rehabilitation, Myocardial Ischemia, Physical Exercise, Cardiovascular Risk Factors, Randomized Controlled Trial
Brief summary
Main objective: To assess the efficacy of a phase III cardiac rehabilitation program (CRP), based on counseling in the maintenance of physical exercise (time of physical exercise per week) for patients with myocardial ischemia (MI), once the supervised physical exercise program of phase II of CRP is completed. Secondary objectives: To assess the efficacy of a phase III program of CRP based on counseling in the maintenance of physical exercise for the patient with MI in: 1) the energy expenditure per week, 2) body mass index and abdominal perimeter, 3) control of cardiovascular risk factors (smoking, high blood pressure, dyslipidemia and diabetes mellitus), 4) quality of life related to health, 5) assess the adherence to cardiac pharmacological treatment. Method: Randomized clinical trial in conglomerates, open and controlled. The intervention group will carry out phase III of CRP based on counseling in the maintenance of physical exercise. The control group will receive the usual care. The main outcome will be the physical exercise time per week after finish the supervised physical exercise program of phase II of CRP and at 6 and 12 month later according to the 7-day Physical Activity Recall.
Interventions
OTHERMaintenance of physical exercise
Objectives will be established with the patient to increase the practice of physical exercise and reinforce the control of cardiovascular risk factors (CVRF) and the maintenance of a long-term cardio-healthy lifestyle.
Sponsors
Institut Català de la Salut
Núria Santaularia Capdevila
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients diagnosed with myocardial ischemia, angina pectoris, other specific forms of chronic ischemic heart disease or unspecified ischemic heart disease. * Patients who have completed the supervised physical exercise program of phase II of the CRP. * Absence of cognitive deficit (Pfeiffer test: 0-2 mistakes). * Sufficient functional capacity to follow the CRP (Barthel index \>60) * Residence in catchment area of Bages and Moianès. * Providing signed informed consent.
Exclusion criteria
* Symptoms of right heart failure producing pulmonary hypertension. * Dyspnea caused by severe pulmonary pathology. * Additional comorbidities affecting the prognosis of cardiac disease. * Major comorbidities or limitations that could interfere with the exercise training programme.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The physical exercise minutes performed by the patient per week | At baseline, when the supervised physical exercise program of phase II of the CRP has been completed. | The physical exercise minutes performed by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Low-density lipoproteins cholesterol | At baseline, when the supervised physical exercise program of phase II of the CRP has been completed. | Physiological parameter |
| The energy expenditure by the patient per week | At baseline, when the supervised physical exercise program of phase II of the CRP has been completed. | The energy expenditure by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire. |
| The body mass index (BMI) | At baseline of the supervised physical exercise program of phase II of the CRP has been completed. | BMI is the quotient between the weight (kg) and the square of the height (m). It is usually used for the definition of underweight (BMI \<15.99), normal weight (BMI 18.5 to 24.99), overweight (BMI ≥ 25 kg / m2) and obesity (BMI ≥ 30 kg / m2). |
| The abdominal circumference | At baseline of the supervised physical exercise program of phase II of the CRP has been completed. | Abdominal circumference is the measurement of the abdomen of the patient at the level of the navel. It will be recorded in centimeters using a tape measure. |
| The control of smoking | At baseline, when the supervised physical exercise program of phase II of the CRP has been completed. | Smoking:The degree of dependence on tobacco consumption will be recorded through the Fargeström test. |
| Systolic blood pressure | At baseline, when the supervised physical exercise program of phase II of the CRP has been completed. | Physiological parameter |
| High-density lipoproteins cholesterol | At baseline, when the supervised physical exercise program of phase II of the CRP has been completed. | Physiological parameter |
| Total cholesterol | At baseline, when the supervised physical exercise program of phase II of the CRP has been completed. | Physiological parameter |
| Triglycerides | At baseline, when the supervised physical exercise program of phase II of the CRP has been completed. | Physiological parameter |
| Basal plasma glucose | At baseline, when the supervised physical exercise program of phase II of the CRP has been completed. | Physiological parameter |
| The quality of life related to health. | At baseline, when the supervised physical exercise program of phase II of the CRP has been completed. | Level of perception of the patient regarding their state of health. It will be measured through the EuroQol-5D test. |
| Assess the adherence to cardiovascular medication. | At baseline, when the supervised physical exercise program of phase II of the CRP has been completed. | It will be recorded if the patient is successfully taking the cardiovascular medication through the Haynes-Sackett test. |
| Diastolic blood pressure | At baseline, when the supervised physical exercise program of phase II of the CRP has been completed. | Physiological parameter |
Countries
Spain
Outcome results
None listed